Godavari Drugs Ltd

Godavari Drugs Ltd

₹ 99.6 -0.04%
12 Apr 4:01 p.m.
About

Incorporated in 1987, Godavari Drugs Ltd manufactures and sale of Active Pharmaceutical Ingredients and their intermediates[1]

Key Points

Business Overview:[1]
Company is in the business of Manufacturing APIs, drug intermediaries, and fine chemicals and caters to the global Life Science Industry. It has an active Loan License and Contract Manufacturing tie-ups with multinational companies for APIs and drug intermediates

  • Market Cap 75.0 Cr.
  • Current Price 99.6
  • High / Low 114 / 76.2
  • Stock P/E 18.4
  • Book Value 46.6
  • Dividend Yield 0.00 %
  • ROCE 14.2 %
  • ROE 11.4 %
  • Face Value 10.0

Pros

  • Company's median sales growth is 23.8% of last 10 years

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
33.10 32.96 44.40 38.67 33.76 44.28 42.55 40.55 39.16 37.37 35.42 39.54 43.11
30.53 30.39 41.31 35.76 31.17 41.58 40.15 37.98 36.89 34.69 33.17 36.47 39.59
Operating Profit 2.57 2.57 3.09 2.91 2.59 2.70 2.40 2.57 2.27 2.68 2.25 3.07 3.52
OPM % 7.76% 7.80% 6.96% 7.53% 7.67% 6.10% 5.64% 6.34% 5.80% 7.17% 6.35% 7.76% 8.17%
0.08 0.11 0.02 0.09 0.05 0.12 0.07 0.13 0.30 0.39 0.45 0.00 -0.01
Interest 0.82 0.81 0.71 0.79 0.73 0.62 0.74 1.06 1.10 1.03 1.11 1.30 1.27
Depreciation 0.29 0.37 0.42 0.43 0.43 0.42 0.46 0.47 0.51 0.50 0.47 0.49 0.50
Profit before tax 1.54 1.50 1.98 1.78 1.48 1.78 1.27 1.17 0.96 1.54 1.12 1.28 1.74
Tax % 35.06% 14.00% 28.28% 31.46% 9.46% 29.21% 26.77% 26.50% 30.21% 13.64% 27.68% 32.81% 29.89%
1.00 1.29 1.42 1.22 1.33 1.27 0.92 0.86 0.67 1.33 0.81 0.86 1.22
EPS in Rs 1.33 1.71 1.89 1.62 1.77 1.69 1.22 1.14 0.89 1.77 1.08 1.14 1.62
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
4 8 9 55 71 76 64 84 96 123 161 160 155
4 6 8 49 67 70 60 78 90 113 150 150 144
Operating Profit -1 2 2 6 4 5 4 5 6 10 11 10 12
OPM % -15% 21% 20% 11% 6% 7% 6% 7% 6% 8% 7% 6% 7%
0 0 0 0 0 1 1 0 0 0 0 1 1
Interest 0 0 0 1 2 3 2 3 3 3 3 4 5
Depreciation 1 1 1 1 1 1 1 1 1 1 2 2 2
Profit before tax -2 1 1 5 2 3 1 2 2 6 7 5 6
Tax % 0% 33% -121% 23% 38% 33% 37% 31% 13% 28% 25% 23%
-2 0 2 4 1 2 1 1 2 4 5 4 4
EPS in Rs -2.12 0.64 2.06 4.85 1.79 2.40 1.10 1.61 2.66 5.48 6.97 5.03 5.61
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 36%
5 Years: 20%
3 Years: 19%
TTM: -7%
Compounded Profit Growth
10 Years: 22%
5 Years: 34%
3 Years: 22%
TTM: 9%
Stock Price CAGR
10 Years: 25%
5 Years: 34%
3 Years: 21%
1 Year: 24%
Return on Equity
10 Years: 14%
5 Years: 14%
3 Years: 16%
Last Year: 11%

Balance Sheet

Figures in Rs. Crores

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 8 8 8 8 8 8 8 8 8 8 8 8 8
Reserves -0 0 2 6 7 9 10 11 13 17 22 26 28
2 2 2 8 16 16 19 22 28 30 23 36 34
6 5 3 13 21 24 27 33 36 36 49 52 58
Total Liabilities 15 15 15 35 51 56 63 74 84 91 101 121 127
8 7 8 7 9 13 15 15 14 22 26 25 24
CWIP 0 0 0 0 1 0 1 2 9 1 0 9 13
Investments 0 0 0 0 0 0 0 0 0 0 0 0 0
7 7 7 27 41 43 47 57 61 68 75 87 90
Total Assets 15 15 15 35 51 56 63 74 84 91 101 121 127

Cash Flows

Figures in Rs. Crores

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
0 1 2 -6 -5 5 4 4 6 1 11 13
-1 -1 -2 -0 -2 -3 -3 -2 -7 -1 -5 -9
1 1 0 6 7 -2 -0 -1 0 0 -6 -4
Net Cash Flow -0 0 -0 0 0 0 1 -0 -0 0 1 1

Ratios

Figures in Rs. Crores

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 40 32 20 87 126 117 152 148 137 134 126 132
Inventory Days 1,253 1,484 973 84 67 70 100 93 84 55 28 57
Days Payable 554 284 179 79 108 124 171 171 144 112 121 132
Cash Conversion Cycle 739 1,231 814 92 85 63 81 70 78 78 33 58
Working Capital Days 177 147 120 95 104 95 112 95 88 86 52 73
ROCE % -15% 9% 8% 32% 16% 17% 11% 12% 12% 18% 18% 14%

Shareholding Pattern

Numbers in percentages

Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
55.86% 56.13% 56.13% 56.13% 56.36% 56.92% 56.92% 53.12% 53.12% 53.16% 53.16% 53.16%
0.50% 0.50% 0.50% 0.50% 0.50% 0.50% 0.50% 0.50% 0.50% 0.50% 0.50% 0.50%
43.65% 43.38% 43.38% 43.38% 43.15% 42.58% 42.58% 46.37% 46.39% 46.34% 46.33% 46.35%
No. of Shareholders 4,1364,5675,3945,7506,0346,2325,9686,6516,5556,5617,0196,894

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents